GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Hash Corp (XCNQ:REZN) » Definitions » Capex-to-Revenue

The Hash (XCNQ:REZN) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is The Hash Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

The Hash's Capital Expenditure for the three months ended in Dec. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was C$0.11 Mil.

Hence, The Hash's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


The Hash Capex-to-Revenue Historical Data

The historical data trend for The Hash's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Hash Capex-to-Revenue Chart

The Hash Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
- - 0.20 0.01 -

The Hash Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of The Hash's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, The Hash's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hash's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Hash's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where The Hash's Capex-to-Revenue falls into.



The Hash Capex-to-Revenue Calculation

The Hash's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.554
=0.00

The Hash's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.107
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Hash  (XCNQ:REZN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


The Hash Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of The Hash's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


The Hash (XCNQ:REZN) Business Description

Traded in Other Exchanges
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
The Hash Corp is engaged in the production and sale of cannabis-based hashish and other cannabis products. It applies its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additive and carcinogenic solvents.

The Hash (XCNQ:REZN) Headlines

No Headlines